Drug
Avi 4020
Avi 4020: highest development phase Phase 1, developed by Sarepta Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AVI-4020 Injection NCT00387283 | Phase 1 | West Nile Virus |
| AVI-4020 Injection NCT00091845 | Phase 1 | West Nile Fever |
Latest
No recent events.
Follow Avi 4020 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.